<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368281">
  <stage>Registered</stage>
  <submitdate>28/02/2017</submitdate>
  <approvaldate>3/03/2017</approvaldate>
  <actrnumber>ACTRN12617000339358</actrnumber>
  <trial_identification>
    <studytitle>End-tidal oxygen achieved with preoxygenation via non-rebreather mask at different flow rates in healthy volunteers</studytitle>
    <scientifictitle>Efficacy of preoxygenation via non-rebreather mask, comparing standard oxygen flow at 15lpm to maximally opened flow meter in healthy participants</scientifictitle>
    <utrn />
    <trialacronym>nil</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intubation</healthcondition>
    <healthcondition>preoxygenation</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The study design is two-period crossover study (repeated measures design) . Participants will complete two trials of 3-minutes pre-oxygenation via non-rebreather mask (NRM)., One trial will have an oxygen flow rate of 15lpm, The other will have the flow-meter valve turned wide open. The end-tidal oxygen (ETO2) will be measured at the end of each trial. The first trial will be followed by a washout period of 2 minutes. Allocation to the first trial (15lpm or fully open valve) will be randomised. </interventions>
    <comparator>The NRM at 15l/min is the control. </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>End-tidal oxygen after 3-minutes of preoxygenation will be assessed with a paramagnetic oxygen analyser from a standard anaesthetic machine. The same analyser will be used for all trials.</outcome>
      <timepoint>at 3 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>No regular cardiovascular or respiratory medication, no history of chronic respiratory disease.

Attendees at NSW Ambulance Aeromedical service governance days. We are not allowed to recruit outside of this site.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Pregnancy, lung disease, known or suspected coronary or cerebrovascular disease, treatment for asthma or
COPD, previous exposure to bleomycin, participants with beards, dentures or facial abnormalities affecting mask
seal.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The order of trials will be randomised. This randomisation will be performed using a random sequence generated using the statistical software “R”. Allocation is not concealed.</concealment>
    <sequence>Random sequence generation by statistical software package.
</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>balanced Latin-Squares design. This allows the sequence of trials to be randomised, but balanced so that, if one participant was to conduct the trials in a particular order, another participant will perform their trials in the reverse of that order.</designfeatures>
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods>Analysis will be by paired hypothesis test depending on parametric or non-parametric distribution of the data</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/05/2016</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize>40</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>31/05/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>NSW Ambulance</primarysponsorname>
    <primarysponsoraddress>Aeromedical Services
Drover Road
Bankstown Airport
2200
NSW
</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Ambulance NSW</fundingname>
      <fundingaddress>Aero medical and retrieval services 
Drover Rd 
Bankstown 
Nsw 2200</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress>nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Preoxygenation is critical to safe emergency airway management. Outside of the operating theatre and in prehospital environments, Over flow from a standard wall/cylinder outlet has been proposed to greatly enhance preoxygenation via a Non-rebreather mask (NRB).  Methods We performed a randomised crossover trial using two preoxygenation conditions; a NRB at 15lpm and the other a NRB with the 15lpm flowmeter with the dial turned all 
the way open (over-flow). End-tidal oxygen (ETO2) as a measure of preoxygenation/denitrogenating efficacy, was measured by single exhaled vital capacity breath.  </summary>
    <trialwebsite />
    <publication>Hayes-Bradley C, Mcquade D, Miller M. Preoxygenation via a non-rebreather mask comparing a standard oxygen flowmeter rate of 15?Lpm to maximally open. Emerg Med Australas 2017; 59: 165 . epub ahead of print. http://doi.wiley.com/10.1111/1742-6723.12784


</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Local Health District</ethicname>
      <ethicaddress>Research Ethics and Governance Office (REGO)
Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN NSW 2050</ethicaddress>
      <ethicapprovaldate>11/02/2016</ethicapprovaldate>
      <hrec>HREC/15/RPAH/587</hrec>
      <ethicsubmitdate>9/12/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>David McQuade</name>
      <address>Department of Emergency Medicine
Wellington Hospital
Riddiford St, Newtown, 
Wellington 6021, 
</address>
      <phone> +64 4385 5999</phone>
      <fax />
      <email>davidmcq@gmail.com</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Matthew Miller</name>
      <address>Department of Anaesthesia
Toronto Western Hospital,
399 Bathurst St, 
Toronto, 
ON M5T 2S8, 
Canada</address>
      <phone>+1 4162784580</phone>
      <fax />
      <email>mattdotmiller@gmail.com</email>
      <country>Canada</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Matthew Miller</name>
      <address>Department of Anaesthesia
Toronto Western Hospital,
399 Bathurst St, 
Toronto, 
ON M5T 2S8, 
Canada</address>
      <phone>+1 416 278 4580</phone>
      <fax />
      <email>mattdotmiller@gmail.com</email>
      <country>Canada</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Matthew Miller</name>
      <address>Department of Anaesthesia
Toronto Western Hospital,
399 Bathurst St, 
Toronto, 
ON M5T 2S8, 
Canada</address>
      <phone />
      <fax />
      <email />
      <country>Canada</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>